Cargando…
Efficacy and safety of intracoronary prourokinase during percutaneous coronary intervention in treating ST-segment elevation myocardial infarction patients: a randomized, controlled study
BACKGROUND: Prourokinase is a single-chain plasminogen activator presenting with fewer hemorrhagic complications and reduced reocclusion rate compared with the conventional fibrinolytic agents in patients with coronary artery disease. However, prourokinase intracoronary injection during PCI for trea...
Autores principales: | Wu, Yanqiang, Fu, Xianghua, Feng, Qiang, Gu, Xinshun, Hao, Guozhen, Fan, Weize, Jiang, Yunfa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7318521/ https://www.ncbi.nlm.nih.gov/pubmed/32590944 http://dx.doi.org/10.1186/s12872-020-01584-0 |
Ejemplares similares
-
Safety and efficacy study of prourokinase injection during primary percutaneous coronary intervention in acute ST-segment elevation myocardial infarction
por: Jiang, Wenlong, et al.
Publicado: (2020) -
Safety and efficacy of intracoronary recombinant human prourokinase administration in patients with acute myocardial infarction and ST‑segment elevation: A meta‑analysis of randomized controlled trials
por: Fan, Gang, et al.
Publicado: (2022) -
Effects of intracoronary low-dose prourokinase administration on ST-segment elevation in patients with myocardial infarction and a high thrombus burden: a randomized controlled trial
por: Cao, Mingkun, et al.
Publicado: (2022) -
The Usefulness of Intracoronary Imaging in Patients with ST-Segment Elevation Myocardial Infarction
por: Karamasis, Grigoris V., et al.
Publicado: (2023) -
Effects of different strategies on high thrombus burden in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary catheterization
por: Xiao, Yuyang, et al.
Publicado: (2019)